Detalhe da pesquisa
1.
Addressing an HIV cure in LMIC.
Retrovirology
; 18(1): 21, 2021 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34344423
2.
High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations.
J Antimicrob Chemother
; 76(11): 2965-2974, 2021 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34453542
3.
Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda.
J Antimicrob Chemother
; 75(12): 3525-3533, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32853364
4.
Higher sequence diversity in the vaginal tract than in blood at early HIV-1 infection.
PLoS Pathog
; 14(1): e1006754, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29346424
5.
Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial.
Clin Infect Dis
; 68(7): 1184-1192, 2019 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30060027
6.
First-line HIV treatment failures in non-B subtypes and recombinants: a cross-sectional analysis of multiple populations in Uganda.
AIDS Res Ther
; 16(1): 3, 2019 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30670037
7.
Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
PLoS Med
; 14(11): e1002432, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29136032
8.
Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure.
Antimicrob Agents Chemother
; 60(6): 3380-97, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27001818
9.
Effective and targeted latency reversal in CD4+ T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infection.
Emerg Microbes Infect
; 13(1): 2327371, 2024 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38444369
10.
High Time to Start Human Immunodeficiency Virus Type 1-Infected Patients on Integrase Inhibitors in Sub-Saharan Africa.
J Infect Dis
; 216(2): 283-284, 2017 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28838151
11.
New antiretroviral inhibitors and HIV-1 drug resistance: more focus on 90% HIV-1 isolates?
FEMS Microbiol Rev
; 47(1)2023 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36130204
12.
Specialized DNA Structures Act as Genomic Beacons for Integration by Evolutionarily Diverse Retroviruses.
Viruses
; 15(2)2023 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851678
13.
Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles.
Nat Commun
; 14(1): 16, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36627271
14.
Dolutegravir response in antiretroviral therapy naïve and experienced patients with M184V/I: Impact in low-and middle-income settings.
Int J Infect Dis
; 105: 298-303, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33722682
15.
The urgent need for more potent antiretroviral therapy in low-income countries to achieve UNAIDS 90-90-90 and complete eradication of AIDS by 2030.
Infect Dis Poverty
; 8(1): 63, 2019 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31370888
16.
Absence of HIV-1 Drug Resistance Mutations Supports the Use of Dolutegravir in Uganda.
AIDS Res Hum Retroviruses
; 34(5): 404-414, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29353487
17.
Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries.
Infect Dis Poverty
; 6(1): 163, 2017 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29202874
18.
HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa.
J Acquir Immune Defic Syndr
; 75(2): e45-e54, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28129253
19.
Once vs twice-daily abacavir and lamivudine in African children.
AIDS
; 30(11): 1761-70, 2016 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27064996
20.
Treatment failure and drug resistance is more frequent in HIV-1 subtype D versus subtype A-infected Ugandans over a 10-year study period.
AIDS
; 27(12): 1899-909, 2013 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-23727942